Caviedes, Ariel
Cabral-Miranda, Felipe
Orellana, Paulina
Hernández, Hernán
Henríquez, Fernando
Gonzalez-Gomez, Raul https://orcid.org/0000-0003-2341-011X
Pizarro, Matias
Migeot, Joaquin
Ochoa-Rosales, Carolina
Gonzalez-Silva, Carolina
Marin-Diaz, Nickole
Coronel-Oliveros, Carlos
Santamaría-García, Hernando
Carmona, Danilo
García, Adolfo M. https://orcid.org/0000-0002-6936-0114
Slachevsky, Andrea
Singleton, Andrew
Qi, Andy Yue https://orcid.org/0000-0003-1914-8710
Lawlor, Brian
Miller, Bruce
Dhooge, Catherine
Pantazis, Caroline
Udeh-Momoh, Chinedu T.
Aguillón, David https://orcid.org/0000-0003-2283-536X
Matallana, Diana L.
Zimmer, Eduardo R. https://orcid.org/0000-0002-5349-0053
Resende, Elisa de Paula França
Farina, Francesca R. https://orcid.org/0000-0002-4410-4368
Cabello, Francisca
Lopera, Francisco https://orcid.org/0000-0003-3986-1484
Zetterberg, Henrik https://orcid.org/0000-0003-3930-4354
Avila-Funes, José Alberto
Acosta-Uribe, Juliana
Possin, Katherine L.
Kosik, Kenneth S. https://orcid.org/0000-0003-3224-5179
Hu, Kun https://orcid.org/0000-0003-0350-3132
Takada, Leonel T.
de Oliveira, Maira Okada
Maito, Marcelo Adrian
Suárez-Calvet, Marc https://orcid.org/0000-0002-2993-569X
Godoy, Maria E.
Behrens, Maria Isabel https://orcid.org/0000-0003-0964-426X
Parra, Mario A.
del Campo, Marta https://orcid.org/0000-0003-2808-3699
Bruno, Martin
Gelvez, Nancy https://orcid.org/0000-0002-3925-1451
Pozo-Castro, Natalia
Cochran, J. Nicholas https://orcid.org/0000-0002-9852-5504
Custodio, Nilton https://orcid.org/0000-0002-8025-3272
Ortega, Rodrigo https://orcid.org/0000-0001-9643-2091
Santibanez, Rodrigo https://orcid.org/0000-0002-2391-4468
de la Cruz, Rolando
Montesinos, Rosa
McDonagh, Sarah
Bandres-Ciga, Sara https://orcid.org/0000-0003-0056-1361
Javandel, Shireen
Brucki, Sonia M. D.
Pina-Escudero, Stefanie D. https://orcid.org/0000-0001-7467-8365
Valcour, Victor
Li, Ziyi
Yokoyama, Jennifer S. https://orcid.org/0000-0001-7274-2634
Ibañez, Agustin https://orcid.org/0000-0001-6758-5101
Duran-Aniotz, Claudia
,
de Paula França Resende, Elisa
de Oliveira, Maira Okada
Article History
Received: 18 May 2025
Accepted: 24 December 2025
First Online: 13 February 2026
Competing interests
: H.Z. has served on scientific advisory boards and/or as a consultant for AbbVie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics and Wave; has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk and Roche; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). Not related to the current work, K.H. is the Honorary Lifetime Co-founder of iFutureLab Inc., serves on the scientific advisory board of the company and has received consulting fees from the company. Z.L.’s participation in this project was part of a competitive contract awarded to DataTecnica LLC by the NIH to support open science research. S.M.D.B. has served on scientific advisory boards and/or as a consultant for Biogen, Lilly, Novo Nordisk and Roche and has received a research productivity grant from the National Council for Scientific and Technological Development (Ministry of Science and Technology−Brazil). M.S.-C. has received consultancy/speaker fees (paid to the institution) in the past 36 months from Almirall, Lilly, Quanterix, Novo Nordisk and Roche Diagnostics. He has received consultancy fees from or served on advisory boards (paid to the institution) of Lilly, Grifols, Novo Nordisk and Roche Diagnostics. He was granted a project and is a site investigator of a clinical trial (funded to the institution) by Roche Diagnostics. In-kind support for research (to the institution) was received from ADx Neurosciences, Alamar Biosciences, ALZpath, Avid Radiopharmaceuticals, Lilly, Fujirebio, Janssen Research & Development, Meso Scale Discovery and Roche Diagnostics. M.S.-C. did not receive any personal compensation from these organizations or any other for-profit organization. The other authors declare no competing interests.